Iron Overload in Chronic Kidney Disease: Less Ferritin, More T2*MRI

Abdulqadir J. Nashwan; Mohamed A. Yassin; Mohamed Izham Mohamed Ibrahim; Hanan F. Abdul Rahim; Mujahed Shraim

doi:10.3389/fmed.2022.865669

Frontiers in Medicine (Mar 2022)

Iron Overload in Chronic Kidney Disease: Less Ferritin, More T2*MRI

Abdulqadir J. Nashwan,
Mohamed A. Yassin,
Mohamed Izham Mohamed Ibrahim,
Hanan F. Abdul Rahim,
Mujahed Shraim

Affiliations

Abdulqadir J. Nashwan: Department of Nursing, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar
Mohamed A. Yassin: Hematology and Oncology, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar
Mohamed Izham Mohamed Ibrahim: College of Pharmacy, QU Health, Qatar University, Doha, Qatar
Hanan F. Abdul Rahim: Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar
Mujahed Shraim: Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar

DOI: https://doi.org/10.3389/fmed.2022.865669
Journal volume & issue: Vol. 9

Abstract

Read online

To date, there is no consensus on the most reliable marker of iron status in patients with chronic kidney disease (CKD). Serum ferritin is used routinely, although it may be a misleading marker for iron overload. The success of T2* MRI in monitoring iron overload in patients with hemoglobinopathies can be beneficial to monitoring patients with CKD.

Published in Frontiers in Medicine

ISSN: 2296-858X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Medicine (General)
Website: http://www.frontiersin.org/journals/medicine

About the journal

Abstract

Keywords